Received: 27 March 2022
Accepted: 18 October 2022
First Online: 12 November 2022
: This prospective randomized, double-blind controlled trial was reviewed and approved by the IIT Ethics Review Panel of the Clinical Research Ethics Committee of the First Hospital of Zhejiang University School of Medicine on 06/05/2020 (Session No. 48). The study was registered in the China Clinical Trials Registry on 30/05/2020 (Registration No.ChiCTR2000033380). Written informed consent was obtained from all participants.
: Not applicable.
: The authors have no relevant financial or non-financial interests to disclose.